Log In
Print
BCIQ
Print
Print this Print this
 

tetravalent dengue vaccine

Also known as: ChimeriVax (ChimeriVax-Dengue)

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionChimeric tetravalent dengue vaccine consisting of live attenuated yellow fever virus 17D strain with structural genes replaced with the corresponding dengue structural genes
Molecular Target Not available
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPhase III
Standard IndicationDengue fever
Indication DetailsPrevent dengue fever
Regulatory Designation

U.S. - Fast Track (Prevent dengue fever)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today